NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Abstract

A B S T R A C T Recessive congenital methemoglobinemia (RCM) is due to the homozygous deficiency of NADH-cytochrome b5 reductase (EC 1.6.2.2.). In type I disease, in which the patients are only methemoglobinemic, the enzyme defect is fully expressed in the erythrocytes, whereas the leukocytes are much less affected. In type II disease, in which the patients are, in addition, mentally retarded, the defect is generalized to all the tissues including cultured fibroblasts. In the present study we have investigated Epstein-Barr virus (EBV) transformed lymphoid cell lines (LCL) derived from patients with both types of cytochrome b5 reductase deficiency and from nondeficient individuals. The total cytochrome b5 reductase activity of the control LCL was found to be similar whatever the LCL origin, except for one lymphoma line (Daudi). The enzyme from the control LCL (C 252/B 95) was found to be immunologically related to the human soltuble erythrocyte cytochrome b5 reductase, indicating that it is the product of the same gene: the DIA, (diaphorase) locus. The LCL derived from one patient with the type I disease and two patients with the type II disease were investigated. In the former the defect was expressed to a lesser degree than in the cases with mental retardation in which the defect was much pronounced, and involved both the mitochondrial and the microsomal fractions. This indicates that all the subcellular forms of the cytochrome b5 reductase are under the same genetic control. Altogether, these data show that the LCL are a favorable material for studying both types of cytochrome b5 reductase deficiency and for in-

Sphingosine kinase 1–mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells

“…The use of LCLs has been previously proven to be instrumental in uncovering important pathogenic mechanisms in other diseases, such as hypertension, glycogen and lipid storage diseases, chronic granulomatous disease, hematologic disorders, and solid tumors (27)(28)(29)(30)(31)(32)(33). One illustrative example is essential hypertension.…”

Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

“…Total RNA was extracted from mononuclear cells and whole liver tissue (35), and genomic DNA was extracted from PMN and whole liver tissue (36). The peripheral blood sample was also used to establish EBV-transformed lymphoblasts (EBVTL) from five patients (37), which were used as an additional source of RNA and genomic DNA. A mononuclear cell preparation was prepared from heparinized blood samples from five healthy individuals, and EBVTL from 5 individuals with nonporphyric disorders (colon cancer, Wilms's tumor, lysencephalopathy, albinism, and asthma).…”

Kinetic and catalytic performance of a BI‐porous composite material in catalytic cracking and isomerisation reactions

“…The use of LCLs has been previously proven to be instrumental in uncovering important pathogenic mechanisms in other diseases, such as hypertension, glycogen and lipid storage diseases, chronic granulomatous disease, hematologic disorders, and solid tumors (27–33). One illustrative example is essential hypertension.…”